Description
Description: Velpaclear tablets are an innovative combination medication manufactured by Abbott India Ltd. Each pack contains 28 tablets, each tablet containing a combination of two potent antiviral agents: Velpatasvir (100 mg) and Sofosbuvir (400 mg). This medication is formulated to provide effective treatment for chronic hepatitis C virus (HCV) infection in adults.
Active Ingredients: Velpaclear tablets contain two active ingredients:
- Velpatasvir: A pan-genotypic NS5A inhibitor that targets the hepatitis C virus protein NS5A, interfering with its function and preventing viral replication.
- Sofosbuvir: A nucleotide analog NS5B polymerase inhibitor that inhibits the replication of the hepatitis C virus by acting as a chain terminator during viral RNA synthesis.
Manufacturer: Velpaclear tablets are manufactured by Abbott India Ltd., a leading global healthcare company known for its commitment to developing innovative medications and improving patient outcomes. Abbott India Ltd. adheres to stringent quality standards in the production of pharmaceutical products.
Strength: Each Velpaclear tablet contains Velpatasvir 100 mg and Sofosbuvir 400 mg, providing a potent combination therapy for the treatment of chronic hepatitis C virus infection.
Uses: Velpaclear tablets are indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults. This medication is effective against multiple genotypes of the hepatitis C virus and may be used alone or in combination with other antiviral agents, depending on the specific genotype and treatment history of the patient.
How to Use: Velpaclear tablets should be taken orally once daily with or without food, as directed by a healthcare professional. The dosage and duration of treatment will vary depending on factors such as the genotype of the hepatitis C virus, the patient’s liver function, and previous treatment history. It is essential to follow the prescribed regimen and complete the full course of treatment as directed.
Storage Conditions: Velpaclear tablets should be stored according to the manufacturer’s instructions, typically at room temperature away from heat, light, and moisture. The tablets should be kept in their original packaging and out of reach of children and pets.
Precautions:
- Velpaclear tablets should be used with caution in patients with certain medical conditions, such as severe renal impairment or decompensated liver disease.
- It is essential to monitor liver function, renal function, and viral load regularly during treatment with Velpaclear.
- Patients should be advised to avoid consuming alcohol and to use appropriate contraceptive measures during treatment with Velpaclear, as it may cause harm to the fetus.
Contraindications: Velpaclear tablets are contraindicated in patients with a known hypersensitivity to any of the ingredients in the formulation. It should not be used in pregnant women or breastfeeding mothers.
Side Effects: Common side effects associated with Velpaclear tablets may include headache, fatigue, nausea, diarrhea, and insomnia. These side effects are usually mild and transient. Serious side effects such as liver dysfunction and allergic reactions are rare but may occur. Promptly report any unusual or severe symptoms to a healthcare provider.
Reviews
There are no reviews yet.